Risk and timing of clinical events according to diabetic status of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting stent: 2-year results from a propensity score matched comparison of ABSORB EXTEND and SPIRIT trials

Carlos M. Campos, Adriano Caixeta, Marcelo Franken, Antonio L. Bartorelli, Robert J. Whitbourn, Chiung Jen Wu, Hsien Li Paul Kao, Mohd Ali Rosli, Didier Carrie, Bernard De Bruyne, Gregg W. Stone, Patrick W. Serruys, Alexandre Abizaid

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Risk and timing of clinical events according to diabetic status of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting stent: 2-year results from a propensity score matched comparison of ABSORB EXTEND and SPIRIT trials'. Together they form a unique fingerprint.

Medicine & Life Sciences